Showing results (1-10 of 157) with videos related to
Sort By:
Pageof 16
Cancer Treatment Reviews|April 9, 2016
Thymic malignancies: Moving forward with new systemic treatmentsJ Remon, C R Lindsay, M V Bluthgen, et al.Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experienceM V Bluthgen, C Boutros, F Fayard, et al.Lung Cancer (Amsterdam, Netherlands)|June 20, 2017
CD52, CD22, CD26, EG5 and IGF-1R expression in thymic malignanciesJ Remon, N Abedallaa, E Taranchon-Clermont, et al.Cancer Treatment Reviews|January 23, 2017
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment eraJ Remon, E Le Rhun, B BesseAnnals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
A prospective examination of circulating tumor cell profiles in non-small-cell lung cancer molecular subgroupsC R Lindsay, V Faugeroux, S Michiels, et al.Cancer Treatment Reviews|October 26, 2018
Immunotherapy for oncogenic-driven advanced non-small cell lung cancers: Is the time ripe for a change?J Remon, L E Hendriks, C Cabrera, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Are liquid biopsies a surrogate for tissue EGFR testing?J W Goldman, Z S Noor, J Remon, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2017
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNAJ Remon, C Caramella, C Jovelet, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 19, 2021
Small cell lung cancer: a slightly less orphan disease after immunotherapyJ Remon, M Aldea, B Besse, et al.Revue De Pneumologie Clinique|July 23, 2011
[What is the best sequence of treatment for patients with EGFR mutations?]B Besse, G ZalcmanPageof 16